Skip to content

Al-Neama Ashraf

Active
Private limited companyfounded 2021active for 4 yearsFrank Craeybeckxlaan 7, 2100 Antwerpen, BelgiumKBO/BCE: BE 0779.248.015
Summary

Al-Neama Ashraf has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,766 and a net result of €190,675. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 53% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 22-12-2021 Normal situation
Activity
General medical practice NACE 86210
Joint committee
330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
Establishment unit
2.326.142.152 2100 Antwerpen, since 22-12-2021
Financial year end
31 December
Peppol
Reachable since 31-10-2023

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€301,808
▲ 19.8%
Turnover
≈ €470,000
estimated
Profit
€190,675
▲ 18.7%
Equity
€91,766
▼ 76.0%
Total assets
€139,167
▼ 64.9%
Employees on 31-12-2025
2
=
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.76, cash €82,680, halvedSize: total assets €139,167Equity €91,766 (65.9% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 52% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 91-9
equity 65.9% of total assets
Liquidity 86-14
short-term debt 33.1% · cash 59.4%
Profitability 100=
return on assets 137.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025highest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €8,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.76 (30.26 in 2024), above the usual 1.5. Short-term debt is 33.1% and cash 59.4% of total assets. 34.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 53% of them on solvency, 68% on liquidity, 80% on profitability and 8% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.76, cash €82,680, halved
NBB · annual accounts
lowers risk · Size: total assets €139,167
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €91,766 (65.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-04-2026, 99 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
99 days early
2024
135 days early
2023
8 days early
2022
12 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 64 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 June (3 of the last 4 accounts filed within 48 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €382,801 to €91,766 ▼ 76.0% View
  • Positive: Higher net result than 86% of companies in human healthsector median €60,150 · 20,693 companies €190,675 View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed IncorporationStarting capital €2,000 · Appointment: AL-NEAMA Ashraf (director)
All 7 events

Comparable companies

These companies have the same main activity as Al-Neama Ashraf: general medical practice (NACE 86210). They are comparable in size and age: total assets between €123,000 and €201,000, founded between 2019 and 2022.

CompanyTotal assetsGross margin
Al-Neama Ashraf Antwerpen€139,167€301,808
Renwart Medical Schaarbeek€123,408€332,945
BULCKUS Gent€168,755€267,992
Dr. Karen Van Langendonck Kortessem€185,814€267,302
DR. PEERAER KATRIEN Kapellen€200,867€264,785
Dokter Ledegen Lars Antwerpen€179,053€250,044
DR. BRAM DE WALSCHE Grobbendonk€169,636€220,719
Full comparison

Key facts about Al-Neama Ashraf

What is the company number of Al-Neama Ashraf?
The company number of Al-Neama Ashraf is 0779.248.015. The VAT number is the same number with BE in front: BE 0779.248.015.
Where is Al-Neama Ashraf based?
The registered office is at Frank Craeybeckxlaan 7, 2100 Antwerpen.Company details
What does Al-Neama Ashraf do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Al-Neama Ashraf?
The legal form of Al-Neama Ashraf is Private limited company (BV).
When was Al-Neama Ashraf founded?
Al-Neama Ashraf was founded on 22-12-2021.
Is Al-Neama Ashraf still active?
Yes, Al-Neama Ashraf is an active enterprise in the KBO register.
How many employees does Al-Neama Ashraf have?
Al-Neama Ashraf had an average of 2.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Al-Neama Ashraf fall under?
In its 2025 annual accounts, Al-Neama Ashraf states joint committee 330.04 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of Al-Neama Ashraf?
The turnover in financial year 2025 is ≈ €470,000. This figure is estimated from the gross margin of €301,808 and 36 comparable companies (NACE 862). It probably lies between €420,000 and €590,000.
Is Al-Neama Ashraf profitable?
In financial year 2025, Al-Neama Ashraf made a profit of €190,675.
Where can I find the annual accounts of Al-Neama Ashraf?
Al-Neama Ashraf filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Al-Neama Ashraf due?
Al-Neama Ashraf must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.